Essilor International SA
EssilorLuxottica Société anonyme designs, manufactures, and distributes ophthalmic lenses, frames, and sunglasses in North America, the Middle East, Africa, Europe, Latin America, and the Asia-Pacific. It offers lens, eyewear, contact lenses, reading glasses under the Essilor, Varilux, Crizal, Eyezen, Stellest, Xperio, Transitions, Ray-Ban, Oakley, Barberini, KODAK Lens, Nikon, Shamir, eyexpert, … Read more
Essilor International SA (ESLOY) - Net Assets
Latest net assets as of June 2025: $38.41 Billion USD
Based on the latest financial reports, Essilor International SA (ESLOY) has net assets worth $38.41 Billion USD as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($61.93 Billion) and total liabilities ($23.52 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $38.41 Billion |
| % of Total Assets | 62.02% |
| Annual Growth Rate | 16.56% |
| 5-Year Change | 25.01% |
| 10-Year Change | 573.05% |
| Growth Volatility | 95.46 |
Essilor International SA - Net Assets Trend (2001–2024)
This chart illustrates how Essilor International SA's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Essilor International SA (2001–2024)
The table below shows the annual net assets of Essilor International SA from 2001 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $41.00 Billion | +5.43% |
| 2023-12-31 | $38.89 Billion | +1.95% |
| 2022-12-31 | $38.15 Billion | +6.33% |
| 2021-12-31 | $35.88 Billion | +9.38% |
| 2020-12-31 | $32.80 Billion | -7.17% |
| 2019-12-31 | $35.33 Billion | +5.77% |
| 2018-12-31 | $33.40 Billion | +474.53% |
| 2017-12-31 | $5.81 Billion | -17.58% |
| 2016-12-31 | $7.05 Billion | +15.79% |
| 2015-12-31 | $6.09 Billion | +15.82% |
| 2014-12-31 | $5.26 Billion | +30.17% |
| 2013-12-31 | $4.04 Billion | +3.07% |
| 2012-12-31 | $3.92 Billion | +13.39% |
| 2011-12-31 | $3.46 Billion | +13.59% |
| 2010-12-31 | $3.04 Billion | +11.19% |
| 2009-12-31 | $2.74 Billion | +15.72% |
| 2008-12-31 | $2.37 Billion | +9.12% |
| 2007-12-31 | $2.17 Billion | +13.77% |
| 2006-12-31 | $1.91 Billion | +12.91% |
| 2005-12-31 | $1.69 Billion | +25.98% |
| 2004-12-31 | $1.34 Billion | +10.76% |
| 2003-12-31 | $1.21 Billion | -0.38% |
| 2002-12-31 | $1.21 Billion | +0.40% |
| 2001-12-31 | $1.21 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to Essilor International SA's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 1554.6% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $2.36 Billion | 5.84% |
| Common Stock | $82.00 Million | 0.20% |
| Other Comprehensive Income | $1.17 Billion | 2.91% |
| Other Components | $36.76 Billion | 91.05% |
| Total Equity | $40.38 Billion | 100.00% |
Essilor International SA Competitors by Market Cap
The table below lists competitors of Essilor International SA ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Huntington Bancshares Incorporated
NASDAQ:HBANL
|
$39.15 Billion |
|
Siemens Energy AG
PINK:SMNEY
|
$39.16 Billion |
|
Bloom Energy Corp
NYSE:BE
|
$39.20 Billion |
|
China Yangtze Power Co Ltd
SHG:600900
|
$39.27 Billion |
|
MSCI Inc
NYSE:MSCI
|
$38.89 Billion |
|
Muench. Rueckvers. VNA O.N.
LSE:0KFE
|
$38.86 Billion |
|
Axon Enterprise Inc.
NASDAQ:AXON
|
$38.68 Billion |
|
UTD OV. BK-LOC-ADR/1 SD 1
F:UOB0
|
$38.61 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Essilor International SA's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 38,239,000,000 to 40,376,000,000, a change of 2,137,000,000 (5.6%).
- Net income of 2,359,000,000 contributed positively to equity growth.
- Dividend payments of 1,163,000,000 reduced retained earnings.
- Share repurchases of 274,000,000 reduced equity.
- New share issuances of 35,000,000 increased equity.
- Other comprehensive income increased equity by 961,000,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $2.36 Billion | +5.84% |
| Dividends Paid | $1.16 Billion | -2.88% |
| Share Repurchases | $274.00 Million | -0.68% |
| Share Issuances | $35.00 Million | +0.09% |
| Other Comprehensive Income | $961.00 Million | +2.38% |
| Other Changes | $219.00 Million | +0.54% |
| Total Change | $- | 5.59% |
Book Value vs Market Value Analysis
This analysis compares Essilor International SA's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 3.00x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 43.63x to 3.00x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2001-12-31 | $3.02 | $131.71 | x |
| 2002-12-31 | $3.01 | $131.71 | x |
| 2003-12-31 | $2.88 | $131.71 | x |
| 2004-12-31 | $3.08 | $131.71 | x |
| 2005-12-31 | $3.86 | $131.71 | x |
| 2006-12-31 | $4.35 | $131.71 | x |
| 2007-12-31 | $4.99 | $131.71 | x |
| 2008-12-31 | $5.47 | $131.71 | x |
| 2009-12-31 | $6.45 | $131.71 | x |
| 2010-12-31 | $7.06 | $131.71 | x |
| 2011-12-31 | $7.93 | $131.71 | x |
| 2012-12-31 | $8.68 | $131.71 | x |
| 2013-12-31 | $8.81 | $131.71 | x |
| 2014-12-31 | $11.44 | $131.71 | x |
| 2015-12-31 | $13.18 | $131.71 | x |
| 2016-12-31 | $15.26 | $131.71 | x |
| 2017-12-31 | $13.16 | $131.71 | x |
| 2018-12-31 | $61.78 | $131.71 | x |
| 2019-12-31 | $39.44 | $131.71 | x |
| 2020-12-31 | $36.75 | $131.71 | x |
| 2021-12-31 | $39.36 | $131.71 | x |
| 2022-12-31 | $42.02 | $131.71 | x |
| 2023-12-31 | $42.42 | $131.71 | x |
| 2024-12-31 | $43.89 | $131.71 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Essilor International SA utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 5.84%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 8.90%
- • Asset Turnover: 0.41x
- • Equity Multiplier: 1.59x
- Recent ROE (5.84%) is below the historical average (12.43%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2001 | 13.61% | 7.92% | 0.96x | 1.78x | $43.53 Million |
| 2002 | 16.47% | 9.33% | 0.99x | 1.78x | $78.38 Million |
| 2003 | 18.79% | 10.68% | 0.85x | 2.07x | $105.76 Million |
| 2004 | 18.37% | 10.81% | 0.87x | 1.94x | $111.35 Million |
| 2005 | 17.20% | 11.88% | 0.80x | 1.81x | $120.53 Million |
| 2006 | 17.45% | 12.22% | 0.86x | 1.66x | $140.36 Million |
| 2007 | 17.10% | 12.61% | 0.83x | 1.64x | $152.33 Million |
| 2008 | 16.36% | 12.44% | 0.76x | 1.74x | $148.67 Million |
| 2009 | 14.38% | 11.95% | 0.78x | 1.53x | $119.07 Million |
| 2010 | 15.39% | 11.87% | 0.75x | 1.74x | $161.87 Million |
| 2011 | 15.21% | 12.07% | 0.68x | 1.85x | $173.13 Million |
| 2012 | 15.94% | 11.71% | 0.72x | 1.89x | $217.58 Million |
| 2013 | 15.79% | 11.71% | 0.67x | 2.02x | $217.40 Million |
| 2014 | 18.90% | 16.38% | 0.53x | 2.20x | $437.50 Million |
| 2015 | 13.26% | 11.27% | 0.56x | 2.10x | $186.30 Million |
| 2016 | 12.16% | 11.43% | 0.54x | 1.97x | $144.20 Million |
| 2017 | 13.58% | 8.59% | 0.91x | 1.73x | $208.20 Million |
| 2018 | 3.29% | 10.00% | 0.22x | 1.47x | $-2.21 Billion |
| 2019 | 3.10% | 6.19% | 0.33x | 1.51x | $-2.40 Billion |
| 2020 | 0.26% | 0.59% | 0.28x | 1.62x | $-3.14 Billion |
| 2021 | 4.13% | 7.31% | 0.33x | 1.69x | $-2.06 Billion |
| 2022 | 5.75% | 8.79% | 0.40x | 1.62x | $-1.59 Billion |
| 2023 | 5.99% | 9.01% | 0.42x | 1.58x | $-1.53 Billion |
| 2024 | 5.84% | 8.90% | 0.41x | 1.59x | $-1.68 Billion |
Industry Comparison
This section compares Essilor International SA's net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $2,683,526,542
- Average return on equity (ROE) among peers: -32.48%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Essilor International SA (ESLOY) | $38.41 Billion | 13.61% | 0.61x | $38.94 Billion |
| ANGELALIGN TECHNOLOGY INC (AGLFF) | $480.24 Million | 2.52% | 0.41x | $405.57 Million |
| Akoya Biosciences Inc (AKYA) | $-30.16 Million | 0.00% | 0.00x | $16.24 Million |
| Alcon AG (ALC) | $19.68 Billion | 1.70% | 0.48x | $37.82 Billion |
| Align Technology Inc (ALGN) | $3.85 Billion | 10.94% | 0.61x | $11.75 Billion |
| AngioDynamics Inc (ANGO) | $355.71 Million | 3.06% | 0.15x | $354.40 Million |
| Ansell Limited (ANSLF) | $386.33 Million | -0.45% | 0.87x | $2.58 Billion |
| AptarGroup Inc (ATR) | $2.07 Billion | 11.57% | 1.03x | $8.27 Billion |
| AtriCure Inc (ATRC) | $72.60 Million | -15.79% | 0.54x | $1.42 Billion |
| Avinger Inc (AVGR) | $-35.69 Million | 0.00% | 0.00x | $1.26 Million |
| Anteris Technologies Global Corp. Common Stock (AVR) | $9.03 Million | -338.35% | 0.77x | $156.14 Million |